S. Ozen Et Al. , "Is there a heterozygote advantage for familial Mediterranean fever carriers against tuberculosis infections: Speculations remain?," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.20, no.4, 2002
Ozen, S. Et Al. 2002. Is there a heterozygote advantage for familial Mediterranean fever carriers against tuberculosis infections: Speculations remain?. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.20, no.4 .
Ozen, S., Balci, B., Ozkara, S., Ozcan, A., Yilmaz, E., Besbas, N., ... Ozguc, M.(2002). Is there a heterozygote advantage for familial Mediterranean fever carriers against tuberculosis infections: Speculations remain?. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.20, no.4.
Ozen, S Et Al. "Is there a heterozygote advantage for familial Mediterranean fever carriers against tuberculosis infections: Speculations remain?," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.20, no.4, 2002
Ozen, S Et Al. "Is there a heterozygote advantage for familial Mediterranean fever carriers against tuberculosis infections: Speculations remain?." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.20, no.4, 2002
Ozen, S. Et Al. (2002) . "Is there a heterozygote advantage for familial Mediterranean fever carriers against tuberculosis infections: Speculations remain?." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.20, no.4.
@article{article, author={S Ozen Et Al. }, title={Is there a heterozygote advantage for familial Mediterranean fever carriers against tuberculosis infections: Speculations remain?}, journal={CLINICAL AND EXPERIMENTAL RHEUMATOLOGY}, year=2002}